Cargando…
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
The therapeutic properties of plants have been recognised since time immemorial. Many pathological conditions have been treated using plant-derived medicines. These medicines are used as concoctions or concentrated plant extracts without isolation of active compounds. Modern medicine however, requir...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032166/ https://www.ncbi.nlm.nih.gov/pubmed/29799486 http://dx.doi.org/10.3390/ijms19061578 |
_version_ | 1783337451037655040 |
---|---|
author | Thomford, Nicholas Ekow Senthebane, Dimakatso Alice Rowe, Arielle Munro, Daniella Seele, Palesa Maroyi, Alfred Dzobo, Kevin |
author_facet | Thomford, Nicholas Ekow Senthebane, Dimakatso Alice Rowe, Arielle Munro, Daniella Seele, Palesa Maroyi, Alfred Dzobo, Kevin |
author_sort | Thomford, Nicholas Ekow |
collection | PubMed |
description | The therapeutic properties of plants have been recognised since time immemorial. Many pathological conditions have been treated using plant-derived medicines. These medicines are used as concoctions or concentrated plant extracts without isolation of active compounds. Modern medicine however, requires the isolation and purification of one or two active compounds. There are however a lot of global health challenges with diseases such as cancer, degenerative diseases, HIV/AIDS and diabetes, of which modern medicine is struggling to provide cures. Many times the isolation of “active compound” has made the compound ineffective. Drug discovery is a multidimensional problem requiring several parameters of both natural and synthetic compounds such as safety, pharmacokinetics and efficacy to be evaluated during drug candidate selection. The advent of latest technologies that enhance drug design hypotheses such as Artificial Intelligence, the use of ‘organ-on chip’ and microfluidics technologies, means that automation has become part of drug discovery. This has resulted in increased speed in drug discovery and evaluation of the safety, pharmacokinetics and efficacy of candidate compounds whilst allowing novel ways of drug design and synthesis based on natural compounds. Recent advances in analytical and computational techniques have opened new avenues to process complex natural products and to use their structures to derive new and innovative drugs. Indeed, we are in the era of computational molecular design, as applied to natural products. Predictive computational softwares have contributed to the discovery of molecular targets of natural products and their derivatives. In future the use of quantum computing, computational softwares and databases in modelling molecular interactions and predicting features and parameters needed for drug development, such as pharmacokinetic and pharmacodynamics, will result in few false positive leads in drug development. This review discusses plant-based natural product drug discovery and how innovative technologies play a role in next-generation drug discovery. |
format | Online Article Text |
id | pubmed-6032166 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60321662018-07-13 Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery Thomford, Nicholas Ekow Senthebane, Dimakatso Alice Rowe, Arielle Munro, Daniella Seele, Palesa Maroyi, Alfred Dzobo, Kevin Int J Mol Sci Review The therapeutic properties of plants have been recognised since time immemorial. Many pathological conditions have been treated using plant-derived medicines. These medicines are used as concoctions or concentrated plant extracts without isolation of active compounds. Modern medicine however, requires the isolation and purification of one or two active compounds. There are however a lot of global health challenges with diseases such as cancer, degenerative diseases, HIV/AIDS and diabetes, of which modern medicine is struggling to provide cures. Many times the isolation of “active compound” has made the compound ineffective. Drug discovery is a multidimensional problem requiring several parameters of both natural and synthetic compounds such as safety, pharmacokinetics and efficacy to be evaluated during drug candidate selection. The advent of latest technologies that enhance drug design hypotheses such as Artificial Intelligence, the use of ‘organ-on chip’ and microfluidics technologies, means that automation has become part of drug discovery. This has resulted in increased speed in drug discovery and evaluation of the safety, pharmacokinetics and efficacy of candidate compounds whilst allowing novel ways of drug design and synthesis based on natural compounds. Recent advances in analytical and computational techniques have opened new avenues to process complex natural products and to use their structures to derive new and innovative drugs. Indeed, we are in the era of computational molecular design, as applied to natural products. Predictive computational softwares have contributed to the discovery of molecular targets of natural products and their derivatives. In future the use of quantum computing, computational softwares and databases in modelling molecular interactions and predicting features and parameters needed for drug development, such as pharmacokinetic and pharmacodynamics, will result in few false positive leads in drug development. This review discusses plant-based natural product drug discovery and how innovative technologies play a role in next-generation drug discovery. MDPI 2018-05-25 /pmc/articles/PMC6032166/ /pubmed/29799486 http://dx.doi.org/10.3390/ijms19061578 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Thomford, Nicholas Ekow Senthebane, Dimakatso Alice Rowe, Arielle Munro, Daniella Seele, Palesa Maroyi, Alfred Dzobo, Kevin Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery |
title | Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery |
title_full | Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery |
title_fullStr | Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery |
title_full_unstemmed | Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery |
title_short | Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery |
title_sort | natural products for drug discovery in the 21st century: innovations for novel drug discovery |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032166/ https://www.ncbi.nlm.nih.gov/pubmed/29799486 http://dx.doi.org/10.3390/ijms19061578 |
work_keys_str_mv | AT thomfordnicholasekow naturalproductsfordrugdiscoveryinthe21stcenturyinnovationsfornoveldrugdiscovery AT senthebanedimakatsoalice naturalproductsfordrugdiscoveryinthe21stcenturyinnovationsfornoveldrugdiscovery AT rowearielle naturalproductsfordrugdiscoveryinthe21stcenturyinnovationsfornoveldrugdiscovery AT munrodaniella naturalproductsfordrugdiscoveryinthe21stcenturyinnovationsfornoveldrugdiscovery AT seelepalesa naturalproductsfordrugdiscoveryinthe21stcenturyinnovationsfornoveldrugdiscovery AT maroyialfred naturalproductsfordrugdiscoveryinthe21stcenturyinnovationsfornoveldrugdiscovery AT dzobokevin naturalproductsfordrugdiscoveryinthe21stcenturyinnovationsfornoveldrugdiscovery |